Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Tendera

Showing results (51-60 of 131) with videos related to

Pageof 14
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
Early and late results of percutaneous revascularization in patients with ischemic cardiomyopathy and decreased left ventricular ejection fraction. (Revascularisation in Heart Failure Trial, REHEAT Registry)Pawel Buszman, Iwona Szkróbka, Zofia Tendera, et al.
International Journal of Cardiology|August 6, 2010
A comparison of ST elevation versus non-ST elevation myocardial infarction outcomes in a large registry database: are non-ST myocardial infarctions associated with worse long-term prognoses?Lech Polonski, Mariusz Gasior, Marek Gierlotka, et al.
European Heart Journal|August 27, 2023
New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registryAlexandre Gautier, Fabien Picard, Gregory Ducrocq, et al.
JAMA|February 15, 2003
Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS StudyHenry Krum, Ellen B Roecker, Paul Mohacsi, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 11, 2020
Simple risk models to predict cardiovascular death in patients with stable coronary artery diseaseIan Ford, Michele Robertson, Nicola Greenlaw, et al.
European Heart Journal|March 29, 2013
Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trialsKim Fox, Michel Komajda, Ian Ford, et al.
The American Journal of Medicine|June 6, 2015
Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunctionVictoria Hamill, Ian Ford, Kim Fox, et al.
International Journal of Cardiology|July 22, 2014
Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registryMichal Tendera, Kim Fox, Roberto Ferrari, et al.
European Journal of Preventive Cardiology|January 8, 2023
Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromesEmmanuelle Vidal-Petiot, Yedid Elbez, Jules Mesnier, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 2017
Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and HypertensionEmmanuelle Vidal-Petiot, Nicola Greenlaw, Ian Ford, et al.
Pageof 14

Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
Early and late results of percutaneous revascularization in patients with ischemic cardiomyopathy and decreased left ventricular ejection fraction. (Revascularisation in Heart Failure Trial, REHEAT Registry)Pawel Buszman, Iwona Szkróbka, Zofia Tendera, et al.
International Journal of Cardiology|August 6, 2010
A comparison of ST elevation versus non-ST elevation myocardial infarction outcomes in a large registry database: are non-ST myocardial infarctions associated with worse long-term prognoses?Lech Polonski, Mariusz Gasior, Marek Gierlotka, et al.
European Heart Journal|August 27, 2023
New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registryAlexandre Gautier, Fabien Picard, Gregory Ducrocq, et al.
JAMA|February 15, 2003
Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS StudyHenry Krum, Ellen B Roecker, Paul Mohacsi, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 11, 2020
Simple risk models to predict cardiovascular death in patients with stable coronary artery diseaseIan Ford, Michele Robertson, Nicola Greenlaw, et al.
European Heart Journal|March 29, 2013
Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trialsKim Fox, Michel Komajda, Ian Ford, et al.
The American Journal of Medicine|June 6, 2015
Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunctionVictoria Hamill, Ian Ford, Kim Fox, et al.
International Journal of Cardiology|July 22, 2014
Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registryMichal Tendera, Kim Fox, Roberto Ferrari, et al.
European Journal of Preventive Cardiology|January 8, 2023
Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromesEmmanuelle Vidal-Petiot, Yedid Elbez, Jules Mesnier, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 2017
Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and HypertensionEmmanuelle Vidal-Petiot, Nicola Greenlaw, Ian Ford, et al.
Pageof 14